View analytic
Science NOT Science Fiction: Medical Technologies of the Near Future
Moderators
Assistant Director, U Washington
Terri runs the UW Hollomon Health Innovation Challenge, a student entrepreneurship competition, and advises startup companies during their launch phase. She has been co-founder and early on-board at a number of startups in the chemical and biotechnology industries. She consulted...
Read More →
Speakers
Chief Business Officer, Arivale, Inc.
Sean is Chief Business Officer at Arivale. He has spent the past twelve years working in companies that help people achieve better health. Prior to joining Arivale, Sean was the Executive Vice President at Free & Clear, the nation’s leading health coaching company for tobacco cessation...
Read More →
President and CEO, Silene Biotech
Silene Biotech wants to help you to grow a new heart or liver – in case those organs fail later in life and offers consumers a way to store their cells, and retrieve them to use later for regenerative medicine applications and personalized medicine. The company focuses on induced...
Read More →
President and CEO, ID Genomics
Kaveri Parker is a Principal Investigator on a $3,000,000 STTR Phase II grant from NIH/NIAID, and has successfully led the Company’s first financing round. She has also added 9 clinical partners to BactNet’s nationwide clinical consortium, including the Group Health Research Institute...
Read More →
CEO and President, Prevencio, Inc.
Ms. Rhonda F. Rhyne, M.B.A has been the Chief Executive Officer and President of Prevencio, Inc. since October 2013. Ms. Rhyne is a Principal of Rhyne Life Sciences Consulting. She has more than 25 years of experience in health care with both public and private industry companies...
Read More →
President, CEO and Chairman of the Board, Nativis, Inc.
Chris Rivera has more than 30 years of experience in the biotechnology industry. He was the Founder and CEO of Hyperion Therapeutics, which was acquired by Horizon Pharma in 2015, the Senior Vice President and head of Commercial Operations at both Tercica and Genzyme Therapeutics...
Read More →